These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 33130342)
1. Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents. Ahadi H; Shokrzadeh M; Hosseini-Khah Z; Ghassemi Barghi N; Ghasemian M; Emadi E; Zargari M; Razzaghi-Asl N; Emami S Bioorg Chem; 2020 Dec; 105():104383. PubMed ID: 33130342 [TBL] [Abstract][Full Text] [Related]
2. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents. Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341 [TBL] [Abstract][Full Text] [Related]
4. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation. Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382 [TBL] [Abstract][Full Text] [Related]
5. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer. Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds. Wang LP; Xu Z; Deng GY; Xu SL Curr Top Med Chem; 2020; 20(21):1911-1915. PubMed ID: 32493190 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors. Altuğ-Tasa B; Kaya-Çavuşoğlu B; Koparal AT; Turan G; Koparal AS; Kaplancıklı ZA Anticancer Agents Med Chem; 2021; 21(15):2041-2049. PubMed ID: 33390125 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents. Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690 [TBL] [Abstract][Full Text] [Related]
9. Design, microwave assisted synthesis, and molecular modeling study of some new 1,3,4-thiadiazole derivatives as potent anticancer agents and potential VEGFR-2 inhibitors. Atta-Allah SR; AboulMagd AM; Farag PS Bioorg Chem; 2021 Jul; 112():104923. PubMed ID: 33932767 [TBL] [Abstract][Full Text] [Related]
10. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives. Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494 [TBL] [Abstract][Full Text] [Related]
11. 2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action. Kumar S; Hegde M; Gopalakrishnan V; Renuka VK; Ramareddy SA; De Clercq E; Schols D; Gudibabande Narasimhamurthy AK; Raghavan SC; Karki SS Eur J Med Chem; 2014 Sep; 84():687-97. PubMed ID: 25064346 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents. Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309 [TBL] [Abstract][Full Text] [Related]
13. Search for human DNA topoisomerase II poisons in the group of 2,5-disubstituted-1,3,4-thiadiazoles. Plech T; Kaproń B; Paneth A; Wujec M; Czarnomysy R; Bielawska A; Bielawski K; Trotsko N; Kuśmierz E; Paneth P J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1021-6. PubMed ID: 25792499 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives. Zhao HC; Shi YP; Liu YM; Li CW; Xuan LN; Wang P; Zhang K; Chen BQ Bioorg Med Chem Lett; 2013 Dec; 23(24):6577-9. PubMed ID: 24239016 [TBL] [Abstract][Full Text] [Related]
15. Improving the Hsp90 Inhibitors Containing 4-(2,4-Dihydroxyphenyl)-1,2,3-thiadiazole Scaffold: Synthesis, Affinity and Effect on Cancer Cells. Kazlauskas E; Brukstus A; Petrikas H; Petrikaite V; Cikotiene I; Matulis D Anticancer Agents Med Chem; 2017 Nov; 17(11):1593-1603. PubMed ID: 28270068 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety. Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878 [TBL] [Abstract][Full Text] [Related]
17. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line. Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392 [TBL] [Abstract][Full Text] [Related]
18. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents. Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors. Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]